Results 41 to 50 of about 13,217 (287)

Spontaneous bone regeneration in resected non-continuous mandible due to medication-related osteonecrosis of the jaw

Journal of the Korean Association of Oral and Maxillofacial Surgeons, 2021
Few cases of spontaneous bone regeneration after extensive resection of the jaw bone have been reported, but it is more common in young adults or children. In this case, we report spontaneous bone healing in a 73-year-old female patient.
A. Esen, Gokhan Gurses, Sebnem Akkulah
semanticscholar   +1 more source

Symposium: Imaging modalities for drug-related osteonecrosis of the jaw (4), CT and MR imaging findings of antiresorptive agent-related osteonecrosis of the jaws/medication-related osteonecrosis of the jaw (secondary publication)

Japanese Dental Science Review, 2019
Summary: Generally, CT and MR images of antiresorptive agent-related osteonecrosis of the jaw (ARONJ)/medication-related osteonecrosis of the jaw (MRONJ) show nonspecific findings as seen in active osteomyelitis．However, there are some characteristics as
Akira Baba, Hiroya Ojiri, Tazuko K. Goto, Koshi Ikeda, Hideomi Yamauchi, Nobuhiro Ogino, Takuji Mogami   +6 more
doaj   +1 more source

Evaluation of a context-aware chatbot using retrieval-augmented generation for answering clinical questions on medication-related osteonecrosis of the jaw.

Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery
The potential of large language models (LLMs) in medical applications is significant, and Retrieval-augmented generation (RAG) can address the weaknesses of these models in terms of data transparency and scientific accuracy by incorporating current ...
David Steybe, P. Poxleitner, Suad Aljohani, B. B. Herlofson, O. Nicolatou‐Galitis, Vinod Patel, Stefano Fedele, Tae-Geon Kwon, Vittorio Fusco, S. Pichardo, K. Obermeier, Sven Otto, A. Rau, Maximilan F. Russe   +13 more
semanticscholar   +1 more source

Drug assumption and awareness about adverse drug reactions. The right to know. The case of the bone-modyfing agents: a systematic review

Frontiers in Oral Health
IntroductionMedication-related osteonecrosis of the Jaw (MRONJ) is an adverse drug reaction that affects the mandible and maxilla of patients exposed to BMA and AA therapies, causing the progressive destruction and death of bone.
Rodolfo Mauceri, Rodolfo Mauceri, Sonia Arduini, Martina Coppini, Martina Coppini, Martina Coppini, Monica Bazzano, Isabel Trujillo, Giuseppina Campisi   +8 more
doaj   +1 more source

Mandibular Osteonecrosis Associated with Antacid Therapy (Esomeprazole)

European Journal of Case Reports in Internal Medicine, 2019
Introduction: Osteonecrosis of the jaw has been consistently reported in the literature associated to the high-dose intravenous bisphosphonate therapy. However, osteonecrosis can also occur in patients who have other risk factors.
Simone Marconcini, Enrica Giammarinaro, Saverio Cosola, Anna Maria Genovesi, Ugo Covani   +4 more
doaj   +1 more source

The awareness and practice of dentists regarding medication-related osteonecrosis of the jaw and its prevention: a cross-sectional survey

BMC Oral Health, 2021
Background Accurate documentation of a patient’s prior medication use and awareness of side effects associated with anti-osteoporotic agents can assist dentists to prevent medication-related osteonecrosis of the jaw. I aimed to determine the awareness of
A. Lum Han
doaj   +1 more source

Alendronate-Induced Osteonecrosis of the Jaw in an Elderly Female

International Journal of Gerontology, 2012
Background: In recent years, more and more evidence has demonstrated that a rare symptom, osteonecrosis of the jaw, may be associated with long-term use of bisphosphonates.
Bi-Wei Jan, Hui-Wen Liu, Hung Yu, Shen-Chuan Wang, Chung-Ji Liu   +4 more
doaj   +1 more source

Successful treatment of adjunctive teriparatide therapy for medication-related osteonecrosis of the jaw: a report of two cases

Journal of the Korean Association of Oral and Maxillofacial Surgeons
Medication-related osteonecrosis of the jaw (MRONJ) is a refractory disease that can lead to severe destruction of the jaw. As there is no standard protocol for treating MRONJ, various treatments have been studied.
Randy Kim, Sung-Ok Hong, Jae-Woong Jung, M. Lee, Young-Kee Lee, Y. Jee   +5 more
semanticscholar   +1 more source

Drug-induced osteonecrosis of the jaw: the state of the art

Reumatismo, 2017
Osteonecrosis of the jaw (ONJ) is a rare adverse event of antiresorptive drugs such as bisphosphonates (BP) and denosumab (DMAb). The diagnosis of ONJ is considered in cases where exposed bone in the maxillofacial region does not heal within 8 weeks in a
A. Fassio, F. Bertoldo, L. Idolazzi, O. Viapiana, M. Rossini, D. Gatti   +5 more
doaj   +1 more source

Pharmacogenomics of osteonecrosis of the jaw

Bone, 2019
Osteonecrosis of the jaw (ONJ) is a rare but serious drug induced adverse event, mainly associated with the use of antiresorptive medications, such as intravenous (IV) bisphosphonates (BPs) in cancer patients. In this review, we evaluated all the pharmacogenomic association studies for ONJ published up to December 2018.
Guang Yang, Sonal Singh, Yiqing Chen, Issam S. Hamadeh, Taimour Langaee, Caitrin W. McDonough, L. Shannon Holliday, Jatinder K. Lamba, Jan S. Moreb, Joseph Katz, Yan Gong   +10 more
openaire   +3 more sources